FILINGS
| XFOR 0001501697 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2023-08-21 | UPLOAD | View Document | |
| 2023-08-16 | 3 | FORM 3 SUBMISSION | View Document |
| 2023-08-14 | S-3 | S-3 | View Document |
| 2023-08-14 | S-8 | S-8 | View Document |
| 2023-08-11 | 4 | FORM 4 | View Document |
| 2023-08-10 | 10-Q | 10-Q | View Document |
| 2023-08-10 | 8-K | 8-K | View Document |
| 2023-08-03 | 8-K | 8-K | View Document |
| 2023-07-05 | 4 | FORM 4 | View Document |
| 2023-07-05 | 4 | FORM 4 | View Document |
| 2023-06-30 | 144 | View Document | |
| 2023-06-30 | 144 | View Document | |
| 2023-06-26 | 4 | FORM 4 | View Document |
| 2023-06-26 | 4 | FORM 4 | View Document |
| 2023-06-26 | 4 | FORM 4 | View Document |
| 2023-06-23 | 144 | View Document | |
| 2023-06-23 | 144 | View Document | |
| 2023-06-23 | 144 | View Document | |
| 2023-06-21 | 424B3 | 424B3 | View Document |
| 2023-06-20 | EFFECT | View Document | |
| 2023-06-16 | 4 | FORM 4 | View Document |
| 2023-06-16 | 4 | FORM 4 | View Document |
| 2023-06-16 | 4 | FORM 4 | View Document |
| 2023-06-16 | CORRESP | View Document | |
| 2023-06-16 | SC 13G | View Document | |
| 2023-06-16 | UPLOAD | View Document | |
| 2023-06-15 | 8-K | 8-K | View Document |
| 2023-06-15 | 144 | View Document | |
| 2023-06-15 | 144 | View Document | |
| 2023-06-15 | 144 | View Document | |
| 2023-06-14 | 4 | FORM 4 | View Document |
| 2023-06-14 | 4 | FORM 4 | View Document |
| 2023-06-14 | 4 | FORM 4 | View Document |
| 2023-06-14 | 4 | FORM 4 | View Document |
| 2023-06-14 | 4 | FORM 4 | View Document |
| 2023-06-14 | 4 | FORM 4 | View Document |
| 2023-06-09 | S-3 | S-3 | View Document |
| 2023-06-01 | D | View Document | |
| 2023-06-01 | 8-K | 8-K | View Document |
| 2023-05-31 | 4 | FORM 4 | View Document |
| 2023-05-31 | 144 | View Document | |
| 2023-05-26 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 | View Document |
| 2023-05-16 | 8-K | 8-K | View Document |
| 2023-05-04 | 10-Q | 10-Q | View Document |
| 2023-05-04 | 8-K | 8-K | View Document |
| 2023-05-04 | 8-K | 8-K | View Document |
| 2023-05-04 | 8-K | 8-K | View Document |
| 2023-04-27 | DEFA14A | DEFA14A | View Document |
| 2023-04-25 | ARS | ARS | View Document |
| 2023-04-25 | DEFA14A | DEFA14A | View Document |
| 2023-04-25 | DEF 14A | DEF 14A | View Document |
| 2023-03-21 | 8-K | 8-K | View Document |
| 2023-03-21 | 10-K | 10-K | View Document |
| 2023-03-21 | 8-K | 8-K | View Document |
| 2023-03-13 | 4 | FORM 4 | View Document |
| 2023-03-13 | 4 | FORM 4 | View Document |
| 2023-03-13 | 4 | FORM 4 | View Document |
| 2023-03-13 | 4 | FORM 4 | View Document |
| 2023-03-10 | 8-K | 8-K | View Document |
| 2023-02-15 | 4 | FORM 4 | View Document |
| 2023-02-15 | 4 | FORM 4 | View Document |
| 2023-02-15 | 4 | FORM 4 | View Document |
| 2023-02-15 | 4 | FORM 4 | View Document |
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 3 | View Document |
| 2023-02-14 | SC 13G/A | SCHEDULE 13G/A, AMENDMENT #2 | View Document |
| 2023-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2023-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 4 TO THE SCHEDULE 13G | View Document |
| 2023-01-20 | S-8 | S-8 | View Document |
| 2023-01-13 | SC 13G | X4 PHARMACEUTICALS, INC. | View Document |
| 2023-01-06 | 8-K | 8-K | View Document |
| 2023-01-05 | 8-K | 8-K | View Document |
| 2022-12-23 | 8-K | 8-K | View Document |
| 2022-12-20 | SC 13D/A | GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 | View Document |
| 2022-12-09 | 8-K | 8-K | View Document |
| 2022-12-09 | 424B5 | 424B5 | View Document |
| 2022-12-07 | 424B5 | 424B5 | View Document |
| 2022-11-29 | 8-K | 8-K | View Document |
| 2022-11-09 | 4 | FORM 4 | View Document |
| 2022-11-09 | 4 | FORM 4 | View Document |
| 2022-11-09 | 4 | FORM 4 | View Document |
| 2022-11-09 | 4 | FORM 4 | View Document |
| 2022-11-09 | 8-K | 8-K | View Document |
| 2022-11-04 | 4 | FORM 4 | View Document |
| 2022-11-04 | 3 | FORM 3 | View Document |
| 2022-11-03 | 10-Q | 10-Q | View Document |
| 2022-11-03 | 8-K | 8-K | View Document |
| 2022-10-04 | 8-K | 8-K | View Document |
| 2022-09-27 | 8-K | 8-K | View Document |
| 2022-09-01 | 8-K | 8-K | View Document |
| 2022-08-19 | 4 | FORM 4 | View Document |
| 2022-08-19 | 4 | FORM 4 | View Document |
| 2022-08-19 | 4 | FORM 4 | View Document |
| 2022-08-19 | 4 | FORM 4 | View Document |
| 2022-08-11 | DEF 14A | DEF 14A | View Document |
| 2022-08-05 | EFFECT | View Document | |
| 2022-08-05 | 424B3 | 424B3 | View Document |
| 2022-08-05 | 8-K | 8-K | View Document |
| 2022-08-04 | 10-Q | 10-Q | View Document |
| 2022-08-04 | 8-K | 8-K | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
